We are delighted and honoured that Callavid® has been named in this National Institute for Health and Care Research (NIHR) news story highlighting the role NIHR is playing in improving outcomes for women through the UK Government’s revised Women’s Health Strategy. 🇬🇧 As NIHR notes: “NIHR is funding ‘Callavid’ which if approved would be the …
Our colleagues Andrew Lewis and Elham Shirani will be at the third Microbes in Women’s Health Congress in Valencia on 21-22 April. 🇪🇸 We’re excited to meet with existing and new partners for 2 days of talks, panels and networking. Our user convenient Callavid® drug delivery platform will help provide effective colonisation and epithelial adherence …
original article here: https://drug-dev.com/expert-content/the-most-underutilized-route-in-drug-delivery-how-vaginal-therapeutics-are-finally-getting-the-platform-they-deserve/ The Most Underutilized Route in Drug Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve By: Lara Zibners, MD, MMEd, MBA Women are: 51% of the population The majority of prescription drug users (QuickStats, MMWR, 2023) Almost always the medical decision maker for the family (US Dept of Labor) And, …
Inspired by two packed days at the inaugural HERS summit in sunny San Diego ☀️ with such clear momentum across women’s health. But what was particularly energising and impressive was seeing several scientific breakthroughs and growing successes emerging across the space. None of which have been easy. They’ve all been very hard fought, against the …
Calla Lily Clinical Care will be in sunny Southern California! ☀️ We’re delighted to be in Dana Point, CA during the LSI conference from March 16th-20th – one of medtech’s premier partnering events. We’ll also be in San Diego, CA for the Women’s Health Executive & Research Summit (HERS) conference from March 23-24th – an inaugural …
In the beautiful surroundings of Fishmongers Hall in the City of London, it was great to see our co-founder, Lara Zibners MD MMEd MBA, take part in the WHH Women’s Health Horizons event. Her panel, “From Innovation to Impact: Navigating the Complexities of Medical Device Development in Women’s Health,” was extremely well received, reflecting both …
I recently had the privilege of sharing my thoughts on representing Calla Lily Clinical Care in the Milken Institute Health Women’s Health Network while at the London event a few weeks ago. Yes, that is me grabbing a photo with the former first lady. One of the points that I made during my interview was …
Have just about recovered from the 100k+ steps spent at WHX – World Health Expo 🏃, now the world’s largest healthcare conference. Very many new relationships forged and reconnections made, and now comes the critical part to follow-up and explore how connections might become meaningful collaborations. The overriding highlight was being on stage multiple times …
Original article here by Ben Adams photo by TF-Images/Getty Images German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation intravaginal drug delivery approach. London-based Calla Lily is working on several applications for its Callavid product, a tampon-shaped device that can be used as …
I’m excited to be attending MedTech World Middle East this week in Dubai, where I’ll be taking the stage to present our Callavid® drug delivery platform 🏥✨ I’m keen to connect with fellow global innovators, regulators, and industry leaders to discuss the evolving MedTech ecosystem in the Middle East. And am particularly interested in linking …
